title: Splenic arterial portal infusion.
authors.affiliation: Second Department of Surgery, Nippon Medical School First Hospital, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Akimaru
authors.forename: K
authors.initials: K
authors.lastname: Watanabe
authors.forename: S
authors.initials: S
authors.lastname: Masuda
authors.forename: Y
authors.initials: Y
authors.lastname: Mokode
authors.forename: M
authors.initials: M
authors.lastname: Ishioh
authors.forename: H
authors.initials: H
authors.lastname: Oba
authors.forename: T
authors.initials: T
authors.lastname: Shibuya
authors.forename: T
authors.initials: T
authors.lastname: Shoji
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002404:Catheterization / Q000379:methods*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D011169:Portal Vein; D013157:Splenic Artery
chemical_list: D016685:Mitomycin; D004317:Doxorubicin